title: Improving Care for Patients with Dry Eye Symptoms: See What the Experts Say.
abstract: A panel of experts was invited to discuss the following questions: Why does the prevalence of dry eye disease (DED) appear to be increasing? Are you satisfied with the current definition and classification of DED-aqueous deficiency versus evaporative dry eye? Beyond the innate human factors (e.g., genetics), what external factors might contribute to DED? What areas related to DED need to be more fully understood? In examining a patient complaining of dry eye, what is your strategy (e.g., tests, questionnaire)? What is your strategy in unraveling the root cause of a patient's dry eye symptoms that may be shared by many anterior segment diseases? What are the two or three most common errors made by clinicians in diagnosing DED? Why do contact lens (CL) patients complain of dry eye while wearing lenses but not when not wearing lenses? What areas related to CL discomfort need to be more fully understood? What is your most effective strategy for minimizing CL discomfort? With current advances in biotechnology in dry eye diagnostics and management tools, do you think our clinicians are better prepared to diagnose and treat this chronic condition than they were 5 or 10 years ago? Do you foresee any of these new point-of-care tests becoming standard clinical tests in ocular surface evaluation? What treatments are effective for obstructed Meibomian glands secondary to lid margin keratinization? What level of DED would prevent you from recommending an elected ophthalmic surgery? What strategy do you use to help your patients comply with the recommended home therapies? How do you best manage patients whose severity of dry eye symptoms does not necessarily match clinical test results, especially in cases of ocular surface neuropathy? Where do you see dry eye diagnosis and treatment in 10 years or more?
authors.affiliation: *OD, PhD, FAAO †OD, MS, FAAO School of Optometry (both authors), and Clinical Research Center (MCL), University of California, Berkeley, Berkeley, California; and Vision Science Program, University of California, San Francisco, San Francisco, California (both authors).
authors.forename: Meng C
authors.initials: MC
authors.lastname: Lin
authors.forename: Kenneth A
authors.initials: KA
authors.lastname: Polse
mesh_terms: D003261:Contact Lenses / Q000009:adverse effects; D003941:Diagnostic Techniques, Ophthalmological; D015352:Dry Eye Syndromes / Q000145:classification / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D005141:Eyelid Diseases / Q000145:classification / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D008537:Meibomian Glands / Q000473:pathology*; D005791:Patient Care; D015995:Prevalence; D012307:Risk Factors